Goldman Sachs AM, Menlo Ventures, Transformation Capital, and Novartis led a $23m Series C+ funding round in H1, a developer of healthcare data analytics platform. “We see a critical need for H1’s global healthcare network, especially when it comes to improving diversity in clinical trials and improving healthcare equity. H1’s technology already powers a number of critical use cases for large healthcare organizations, and we believe they are uniquely positioned to realize their vision of becoming the central source of truth for actionable data on doctors, research, and treatments," Chase Williams, Goldman Sachs Investor.